Borstnar, S.; Palacova, M. .; Łacko, A. .; Timcheva, C.; Gal-Yam, E. N.; Papazisis, K.; Beniak, J.; Kudela, P.; Rubovszky, G. . Ribociclib Plus Letrozole in Patients With Hormone receptor‐positive, HER2‐negative Advanced Breast Cancer With No Prior Endocrine Therapy: Subgroup Analysis from the Phase 3b CompLEEment‐1 Trial: Subgroup Analysis of the CompLEEment‐1 Trial. Radiol Oncol 2022, 56, 238-247.